BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 29582316)

  • 1. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
    Raparelli V; Pastori D; Pignataro SF; Vestri AR; Pignatelli P; Cangemi R; Proietti M; Davì G; Hiatt WR; Lip GYH; Corazza GR; Perticone F; Violi F; Basili S;
    Intern Emerg Med; 2018 Aug; 13(5):651-660. PubMed ID: 29582316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study.
    Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J
    J Am Med Dir Assoc; 2014 Aug; 15(8):576-81. PubMed ID: 24894999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study.
    Violi F; Davì G; Proietti M; Pastori D; Hiatt WR; Corazza GR; Perticone F; Pignatelli P; Farcomeni A; Vestri AR; Lip GY; Basili S;
    Thromb Haemost; 2016 Apr; 115(4):856-63. PubMed ID: 26740316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrimental Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: New Insights from Umbria Atrial Fibrillation Registry.
    Angeli F; Reboldi G; Trapasso M; Aita A; Ambrosio G; Verdecchia P
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31324041
    [No Abstract]   [Full Text] [Related]  

  • 6. Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.
    Pastori D; Pignatelli P; Saliola M; Carnevale R; Vicario T; Del Ben M; Cangemi R; Barillà F; Lip GY; Violi F
    Int J Cardiol; 2015 Dec; 201():513-6. PubMed ID: 26318513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between carotid intima-media thickness and non valvular atrial fibrillation type.
    Proietti M; Calvieri C; Malatino L; Signorelli S; Corazza GR; Perticone F; Vestri AR; Loffredo L; Davì G; Violi F; Basili S;
    Atherosclerosis; 2015 Feb; 238(2):350-5. PubMed ID: 25555267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)].
    Mazzone C; Carriere C; Grande E; Iorio AM; Barbati G; Zecchin M; Serdoz LV; Cioffi G; Tarantini L; Sinagra G; Scardi S; Di Lenarda A
    G Ital Cardiol (Rome); 2015 Jun; 16(6):361-72. PubMed ID: 26156697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.
    Polovina M; Đikić D; Vlajković A; Vilotijević M; Milinković I; Ašanin M; Ostojić M; Coats AJS; Seferović PM
    Int J Cardiol; 2017 Dec; 249():191-197. PubMed ID: 28986061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive interaction between chronic obstructive pulmonary disease and CHA
    Perticone M; Sciacqua A; Tripepi G; Miceli S; Corrao S; Sesti G; Perticone F
    Int J Cardiol; 2018 Mar; 255():74-79. PubMed ID: 29174184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation.
    Proietti M; Marra AM; Tassone EJ; De Vuono S; Corrao S; Gobbi P; Perticone F; Corazza GR; Basili S; Lip GY; Violi F; Raparelli V; ;
    Am J Cardiol; 2015 Sep; 116(6):877-82. PubMed ID: 26183791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.
    Bucci T; Romiti GF; Shantsila A; Teo WS; Park HW; Shimizu W; Corica B; Proietti M; Tse HF; Chao TF; Frost F; Lip GYH;
    J Am Heart Assoc; 2024 Apr; 13(7):e032785. PubMed ID: 38533983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry.
    Romiti GF; Corica B; Mei DA; Frost F; Bisson A; Boriani G; Bucci T; Olshansky B; Chao TF; Huisman MV; Proietti M; Lip GYH
    Europace; 2023 Dec; 26(1):. PubMed ID: 38266129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation.
    McAlister FA; Wiebe N; Ronksley PE; Healey JS
    Int J Cardiol; 2018 Oct; 269():145-151. PubMed ID: 30077531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation.
    Pignatelli P; Pastori D; Carnevale R; Farcomeni A; Cangemi R; Nocella C; Bartimoccia S; Vicario T; Saliola M; Lip GY; Violi F
    Thromb Haemost; 2015 Mar; 113(3):617-24. PubMed ID: 25392853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
    Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
    Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: a national wide database analysis.
    Yang YM; Shao XH; Zhu J; Zhang H; Liu Y; Gao X; Liu LS; Yu LT; Zhao L; Yu PF; Zhang H; He Q; Gu XD
    Int J Cardiol; 2014 May; 173(2):242-7. PubMed ID: 24630382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid plaque detection improves the predictive value of CHA
    Basili S; Loffredo L; Pastori D; Proietti M; Farcomeni A; Vestri AR; Pignatelli P; Davì G; Hiatt WR; Lip GY; Corazza GR; Perticone F; Violi F;
    Int J Cardiol; 2017 Mar; 231():143-149. PubMed ID: 28087176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
    Romiti GF; Corica B; Pipitone E; Vitolo M; Raparelli V; Basili S; Boriani G; Harari S; Lip GYH; Proietti M;
    Eur Heart J; 2021 Sep; 42(35):3541-3554. PubMed ID: 34333599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.